Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

76 to 100 of 266 results

Regeneron amends investor agreement with Sanofi

Regeneron amends investor agreement with Sanofi

13-01-2014

US biotech firm Regeneron Pharmaceuticals says it has amended and restated its investor agreement with…

BiotechnologyMergers & AcquisitionsRegeneronSanofi

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

13-01-2014

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Alnylam to acquire Merck’s Sirna Therapeutics

Alnylam to acquire Merck’s Sirna Therapeutics

13-01-2014

US RNAi therapeutics specialist Alnylam Pharmaceuticals says it has reached agreement to acquire US pharma…

Alnylam PharmaceuticalsBiotechnologyMerck & CoMergers & AcquisitionsSirna Therapeutics

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

31-12-2013

China’s Walvax Biotech has revealed it plans to acquire a controlling 64% equity stake in Shanghai’s…

Asia-PacificBiosimilarsBiotechnologyChinaMergers & AcquisitionsOncology

Senesco enters merger accord with Fabrus

31-12-2013

USA-based biotech firm Senesco Technologies has agreed to terms and executed a non-binding Letter of…

BiotechnologyFabrusMergers & AcquisitionsOncologySenesco Technologies

Genesis 2013: Astex Pharma’s journey from biotech start-up to $886m success story

Genesis 2013: Astex Pharma’s journey from biotech start-up to $886m success story

16-12-2013

A biotech company’s dream 14-year journey from small start-up to an $886 million takeover bid provided…

Asia-PacificAstex PharmaceuticalsBiotechnologyFinancialInterviewsMergers & AcquisitionsOtsukaUKUSA

Advaxis rockets on out-licensing ADXS-HPV in Asia

09-12-2013

Shares of US cancer drug developer Advaxis leapt 22% to $4.38 in pre-market trading as the company revealed…

AdvaxisADXS-HPVBiotechnologyGlobal BioPharmaLicensingMergers & AcquisitionsOncologyTaiwan Biotech

OncoMed rockets on possible multi-billion dollar deal with Celgene

OncoMed rockets on possible multi-billion dollar deal with Celgene

04-12-2013

US biotech companies OncoMed Pharmaceuticals and Celgene have entered an agreement to jointly develop…

Anti-DLL4BiotechnologyCelgenedemcizumabLicensingMergers & AcquisitionsOMP-21M18OncologyOncoMed PharmaceuticalsResearch

Biozone Pharma plans reverse merger with Cocrystal Discovery

03-12-2013

USA-based Biozone Pharmaceuticals shares dropped nearly 5.5% when it revealed last week it had agreed…

Anti-viralsBiotechnologyBiozone PharmaceuticalsCocrystal DiscoveryMergers & Acquisitions

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Korea’s SillaJen to acquire Jennerex in up to $150 million deal

Korea’s SillaJen to acquire Jennerex in up to $150 million deal

27-11-2013

Privately-held South Korean firm SillaJen says it has executed a definitive merger agreement to acquire…

BiotechnologyJennerexMergers & AcquisitionsOncologyPexa-VecSillaJenTransgene

Clovis Oncology buys Italian firm for $200 million

21-11-2013

US biotech firm Clovis Oncology says it has acquired EOS (Ethical Oncology Science), a privately-held…

BiotechnologyClovis OncologylucitanibMergers & AcquisitionsOncologyServier

Aphios spins off Amylon to develop novel Alzheimer’s disease drug

21-11-2013

US clinical-stage biotech firm Aphios says it has spun-off a subsidiary, Amylon, to finance, develop…

AmylonAPH-1104AphiosBiotechnologyFinancialMergers & AcquisitionsNeurologicalResearch

Collaboration agreement between French firms Vect-Horus and AAA

20-11-2013

French biotech company Vect-Horus has signed a scientific collaboration agreement with Advanced Accelerator…

Advanced Accelerator ApplicationsBiotechnologyCNS DiseasesEuropeLicensingMergers & AcquisitionsVect-Horus

Sorrento to acquire Concortis Biosystems, gaining ADC technology

Sorrento to acquire Concortis Biosystems, gaining ADC technology

15-11-2013

In a second acquisition within a month, USA-based Sorrento Therapeutics says it has entered a definitive…

BiotechnologyConcortis BiosystemsMergers & AcquisitionsSorrento Therapeutics

Rainbow Coral narrows list of regenerative medicine targets

13-11-2013

USA-based Rainbow Coral Corp says it has opened talks with its top target in the regenerative medicine…

BiotechnologyLicensingMergers & AcquisitionsRainbow Biosciences

Report: M&A worth $11 billion in third quarter while Russian market shows promise

Report: M&A worth $11 billion in third quarter while Russian market shows promise

06-11-2013

PricewaterhouseCoopers (PwC) has released its quarterly Life Sciences Deals Insights Quarterly for the…

BiotechnologyEuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Vivaldi Biosciences acquires clinical stage influenza vaccine assets

13-10-2013

Privately-held US biotech firm Vivaldi Biosciences has acquired from Baxter Healthcare R&D assets, including…

Anti-viralsBaxter HealthcareBaxter InternationalBiotechnologyMergers & AcquisitionsVaccinesVivaldi Biosciences

Osiris to sell culture-expanded MSCs business including Prochymal

11-10-2013

USA-based Osiris Therapeutics has entered into an agreement with a wholly-owned subsidiary of Mesoblast…

BiotechnologyFinancialMergers & AcquisitionsMesoblastOsiris TherapeuticsProchymal

OPKO makes strategic investment in biotech firm

11-10-2013

US pharma and diagnostics firm OPKO Health has agreed to make an undisclosed strategic investment in…

BiotechnologyMergers & AcquisitionsOPKO HealthPharmaceuticalZebra Biologics

PharmAkea, Celgene and Bay City Capital collaborate on cancer and fibrotic disease

PharmAkea, Celgene and Bay City Capital collaborate on cancer and fibrotic disease

09-10-2013

PharmAkea Therapeutics and Bay City Capital have entered a strategic collaboration with Celgene designed…

BiotechnologyCelgeneMergers & AcquisitionsNorth AmericaOncologyPharmAkeaResearch

Cellceutix acquires PolyMedix assets from bankruptcy court

09-09-2013

US clinical-stage biopharma firm Cellceutix (OTCBB: CTIX) has acquired substantially all of the assets…

BiotechnologybrilacidinCellceutixMergers & AcquisitionsPharmaceuticalPolyMedixPrurisol

76 to 100 of 266 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top